vs
Side-by-side financial comparison of Nano Dimension Ltd. (NNDM) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $57.8M, roughly 1.2× Nano Dimension Ltd.). Viridian Therapeutics, Inc.\DE runs the higher net margin — -49.0% vs -171.1%, a 122.0% gap on every dollar of revenue. Nano Dimension Ltd. produced more free cash flow last quarter ($-21.1M vs $-84.7M).
Nano Dimension Ltd. is a leading provider of additively manufactured electronics solutions and 3D printing technologies. It designs high-precision 3D printers, related materials, and software for producing printed circuit boards, microelectronics components, and multi-layer electronic devices, serving aerospace, defense, medical, automotive, and industrial electronics segments across global markets.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
NNDM vs VRDN — Head-to-Head
Income Statement — Q4 FY2024 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.8M | $70.6M |
| Net Profit | $-98.8M | $-34.6M |
| Gross Margin | 43.1% | — |
| Operating Margin | -155.1% | -56.7% |
| Net Margin | -171.1% | -49.0% |
| Revenue YoY | — | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $-0.45 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $70.6M | ||
| Q4 24 | $57.8M | — | ||
| Q2 24 | $28.4M | — | ||
| Q2 23 | $29.7M | — |
| Q3 25 | — | $-34.6M | ||
| Q4 24 | $-98.8M | — | ||
| Q2 24 | $-79.2M | — | ||
| Q2 23 | $12.6M | — |
| Q3 25 | — | — | ||
| Q4 24 | 43.1% | — | ||
| Q2 24 | 45.8% | — | ||
| Q2 23 | 44.0% | — |
| Q3 25 | — | -56.7% | ||
| Q4 24 | -155.1% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | -49.0% | ||
| Q4 24 | -171.1% | — | ||
| Q2 24 | -279.4% | — | ||
| Q2 23 | 42.3% | — |
| Q3 25 | — | — | ||
| Q4 24 | $-0.45 | — | ||
| Q2 24 | $-0.35 | — | ||
| Q2 23 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $317.2M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $860.0M | $503.0M |
| Total Assets | $902.5M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $490.9M | ||
| Q4 24 | $317.2M | — | ||
| Q2 24 | $231.8M | — | ||
| Q2 23 | $454.6M | — |
| Q3 25 | — | $503.0M | ||
| Q4 24 | $860.0M | — | ||
| Q2 24 | $870.3M | — | ||
| Q2 23 | $1.1B | — |
| Q3 25 | — | $577.1M | ||
| Q4 24 | $902.5M | — | ||
| Q2 24 | $911.0M | — | ||
| Q2 23 | $1.2B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.9M | $-84.6M |
| Free Cash FlowOCF − Capex | $-21.1M | $-84.7M |
| FCF MarginFCF / Revenue | -36.5% | -120.1% |
| Capex IntensityCapex / Revenue | 3.8% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-84.6M | ||
| Q4 24 | $-18.9M | — | ||
| Q2 24 | $-30.7M | — | ||
| Q2 23 | $-56.1M | — |
| Q3 25 | — | $-84.7M | ||
| Q4 24 | $-21.1M | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | -120.1% | ||
| Q4 24 | -36.5% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | 0.2% | ||
| Q4 24 | 3.8% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | -4.47× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
